What's breaking now, across thousands of outlets.
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
We haven't written up this one. NPR has the full story — the link below goes straight to it.
[New Times] The closure of 109 alcoholic beverage factories in Rwanda within a matter of days was a necessary intervention to protect public health.
The convenience of taking a daily pill to lose weight is attracting a new group of patients to try emerging oral GLP-1 drugs such as Foundayo and Wegovy.
[Independent (Kampala)] Uganda says modern outbreak science has changed what investigators can know. Is it time to rethink the 42-day rule?
Quid-pro-quo vaping policies, ebola vaccine efforts, and more health news from Morning Rounds
A provincial government in Nepal has legalized the use and growing of marijuana for medical purposes despite a national ban.
Expedition Therapeutics, which has raised nearly $300 million to date, is studying a drug it believes to have notable advantages over other COPD treatments either in development or on the market.
